Secondary Spontaneous Pneumothorax in Patients with Sarcoma Treated with Pazopanib

BMC Cancer
07 Oct, 2018 ,

They conducted a retrospective case control study of patients with sarcoma with metastases to the chest with pneumothorax cases and without pneumothorax controls who are treated with Pazopanib Pazopanib does not increase the risk of pneumothorax in patients with sarcoma Presence of cavitary lung nodules/masses and the presence of pleuralbased nodules/masses were found to be risk factors for pneumothorax